Baker Bros. Advisors LP Tyra Biosciences, Inc. Transaction History
Baker Bros. Advisors LP
- $9.86 Billion
- Q2 2025
A detailed history of Baker Bros. Advisors LP transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Baker Bros. Advisors LP holds 10,607 shares of TYRA stock, worth $158,044. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,607
Previous 10,607
-0.0%
Holding current value
$158,044
Previous $98,000
3.06%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding TYRA
# of Institutions
123Shares Held
59.9MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA12.2MShares$182 Million2.55% of portfolio
-
Alta Partners Management Company, L.P. Jackson, WY4.08MShares$60.8 Million93.82% of portfolio
-
Nextech Invest Ag4.06MShares$60.4 Million10.51% of portfolio
-
Nextech Invest, Ltd. Zurich, V84.06MShares$60.4 Million7.35% of portfolio
-
Bvf Inc San Francisco, CA3.94MShares$58.8 Million1.48% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $625M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...